1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Bloomington, Indiana. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Bloomington.
Bloomington, Indiana has 1 SAMHSA-verified addiction treatment center offering 1 residential rehab, 1 dual diagnosis. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Residential treatment programs in Bloomington provide 24/7 structured care in a substance-free environment. These programs typically last 30 to 90 days and include individual therapy, group counseling, and life skills training.
Treatment centers in Bloomington accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Insurance coverage for addiction treatment in Bloomington is governed by the Mental Health Parity and Addiction Equity Act (MHPAEA), which requires plans that cover substance-use treatment to do so at parity with medical/surgical benefits. In practice: if your plan covers a hospitalization for a heart condition, it must cover residential addiction treatment under comparable cost-sharing, day limits, and authorization requirements. The ACA further classifies substance-use disorder treatment as an Essential Health Benefit, meaning individual and small-group marketplace plans must include this coverage.
The intake process at most Bloomington residential programs begins with a comprehensive clinical assessment covering substance-use history (substance, quantity, duration, last use, withdrawal history), mental-health history, physical-health status (including medications and chronic conditions), social context (housing, employment, family, legal), and recovery history (prior treatment episodes, what worked, what didn't). The assessment typically takes 60-90 minutes and produces an initial treatment plan within 72 hours.
Sober living environments (SLEs) in Bloomington and surrounding areas bridge residential treatment and full independent living. SLE quality varies considerably; the National Alliance for Recovery Residences (NARR) provides a certification framework with four quality levels (peer-run to clinically integrated). Reputable Bloomington-area SLEs require drug testing, mutual-support meeting attendance, progressive responsibility (employment, household contribution), and structured-day adherence. Typical stay length is 3-12 months, longer for patients with severe addiction histories.
Pregnant women in Bloomington with active substance use should not stop opioid use abruptly if dependent — withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. Indiana maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and SAMHSA's Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways for this population.
Severe mental illness — schizophrenia, schizoaffective disorder, severe bipolar — requires specialized clinical capacity that not every Bloomington addiction-treatment program maintains. Patients with active psychotic symptoms, recent psychiatric hospitalization, or complex psychiatric medication regimens may need facilities with on-site psychiatric providers, integrated mental-health-and-addiction protocols, and connections to outpatient psychiatric continuity. Admissions screening should explicitly address this fit before the patient commits.
Patients searching for treatment in Bloomington often face decision fatigue: dozens of facilities advertise similar services, success-rate claims are unverifiable, and insurance-coverage details are opaque until the verification call. The pragmatic approach is to screen along a few specific criteria — licensing status, accepted insurance, ASAM-aligned clinical assessment, dual-diagnosis capacity, family involvement, and aftercare planning — rather than to rely on marketing claims or reviews. Each of the Bloomington providers listed has been screened against these criteria before inclusion.
Withdrawal severity is the first clinical screening factor for treatment entry in Bloomington. Patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care — untreated severe alcohol withdrawal carries 5% mortality and severe benzodiazepine withdrawal can be fatal. Opioid use patients face a different pathway: detox-only is rarely effective for opioid use disorder, and evidence-based protocols typically initiate medication-assisted treatment (buprenorphine or methadone) during the stabilization phase.